Anavex Life Sciences Corp (AVXL)

[dadofmarcmax]

Was queried by someone on YMB regarding Neuronetrix participation on the upcoming CTAD presentation.

With Neuronetrix participating on the upcoming CTAD presentation - to me, things seem to be moving along swimmingly.

Look at the press release dated 11/18/2015 on the neuronetrix site titled "Neuronetrix publishes peer-reviewed paper validating the clinical application of ERP biomarkers for use in Alzheimer’s disease"
Neuronetrix states in that PR, “With the use of an integrated hardware/software system for ERP testing and automated data analysis tools, Neuronetrix has established a benchmark for the application of ERP biomarkers in Alzheimer's disease research,” said Dr. Murali Doraiswamy, a professor at the Duke Institute for Brain Sciences, and a scientific advisor to Neuronetrix. Dr Doraiswamy, a co-author on the publication, added that "The development and validation of noninvasive neural markers to assess cognition and screen for early dementia is a high priority for the field."

I believe that with their participation along with AVXL - further clarification about how these ERP biomarkers can be used to demonstrate reversion to the more healthy - non AD control.

I believe that the CTAD presentation will be a segue into the pivotal trial once it is established that ERP biomarkers change as AD worsens or improves. It will be an object measure of progress, especially with early dementia cases - to follow these biomarkers with treatment of 2-73.